Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism

The 'classical' NF-kappaB activation pathway proceeds via IkappaB kinase (IKK)-beta/gamma-mediated phosphorylation, induced ubiquitination and the degradation of small IkappaBs. An alternative, NF-kappaB-inducing kinase and IKK-alpha-dependent pathway, which stimulates the processing of NF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO reports 2003-01, Vol.4 (1), p.82
Hauptverfasser: Mordmüller, Benjamin, Krappmann, Daniel, Esen, Meral, Wegener, Elmar, Scheidereit, Claus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 82
container_title EMBO reports
container_volume 4
creator Mordmüller, Benjamin
Krappmann, Daniel
Esen, Meral
Wegener, Elmar
Scheidereit, Claus
description The 'classical' NF-kappaB activation pathway proceeds via IkappaB kinase (IKK)-beta/gamma-mediated phosphorylation, induced ubiquitination and the degradation of small IkappaBs. An alternative, NF-kappaB-inducing kinase and IKK-alpha-dependent pathway, which stimulates the processing of NF-kappaB2/p100, has recently been suggested. However, no physiological stimulus has been shown to trigger the activation of this pathway. Here we demonstrate that persistent stimulation with lymphotoxin beta (LT-beta) receptor agonists or lipopolysaccharide (LPS), but not with interleukin-1beta, tumour necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate, induces the generation of p52 DNA-binding complexes by activating the processing of the p100 precursor. Induction of p52 DNA-binding activity is delayed in comparison with p50/p65 complexes and depends on de novo protein synthesis. p100 is constitutively and inducibly polyubiquitinated, and both ubiquitination and p52 generation are coupled to continuing p100 translation. Thus, both LT-beta receptor agonists and LPS induce NF-kappaB/p100 processing to p52 at the level of the ribosome.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_12524526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12524526</sourcerecordid><originalsourceid>FETCH-LOGICAL-p546-2bde63523a13c7a18f55f82791bc3a31e3aa2cb0b94613b888206006a5d7b1e63</originalsourceid><addsrcrecordid>eNo1j8tKxDAYRrNQnHH0FSQvEMilSdOlDo4KRTezcDf8udSJtkloOmDf3qLO6oMD58B3gdasUg3hnL2v0HUpn5RS2dT6Cq0Yl7ySXK2RaechH9OUvkPEEB3uQ0459XMBa48wBudxiO5kPX7dkS_IGR5Ilhx_-OhHmEKK2MwYsE1kGiGW_pdBjwe_-DGU4QZddtAXf_u_G7TfPe63z6R9e3rZ3rdLrlKEG-eVkFwAE7YGpjspO83rhhkrQDAvALg11DSVYsJorTlVlCqQrjZsUTfo7i-bT2bw7pDHMMA4H85fxQ_m21Ac</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism</title><source>Electronic Journals Library</source><source>Wiley-Blackwell Journals</source><source>Open Access: PubMed Central</source><source>MEDLINE</source><source>Wiley Free Archive</source><creator>Mordmüller, Benjamin ; Krappmann, Daniel ; Esen, Meral ; Wegener, Elmar ; Scheidereit, Claus</creator><creatorcontrib>Mordmüller, Benjamin ; Krappmann, Daniel ; Esen, Meral ; Wegener, Elmar ; Scheidereit, Claus</creatorcontrib><description>The 'classical' NF-kappaB activation pathway proceeds via IkappaB kinase (IKK)-beta/gamma-mediated phosphorylation, induced ubiquitination and the degradation of small IkappaBs. An alternative, NF-kappaB-inducing kinase and IKK-alpha-dependent pathway, which stimulates the processing of NF-kappaB2/p100, has recently been suggested. However, no physiological stimulus has been shown to trigger the activation of this pathway. Here we demonstrate that persistent stimulation with lymphotoxin beta (LT-beta) receptor agonists or lipopolysaccharide (LPS), but not with interleukin-1beta, tumour necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate, induces the generation of p52 DNA-binding complexes by activating the processing of the p100 precursor. Induction of p52 DNA-binding activity is delayed in comparison with p50/p65 complexes and depends on de novo protein synthesis. p100 is constitutively and inducibly polyubiquitinated, and both ubiquitination and p52 generation are coupled to continuing p100 translation. Thus, both LT-beta receptor agonists and LPS induce NF-kappaB/p100 processing to p52 at the level of the ribosome.</description><identifier>ISSN: 1469-221X</identifier><identifier>PMID: 12524526</identifier><language>eng</language><publisher>England</publisher><subject>Adaptor Proteins, Signal Transducing ; Adenocarcinoma - pathology ; B-Lymphocytes - drug effects ; B-Lymphocytes - metabolism ; Breast Neoplasms - pathology ; Dendritic Cells - drug effects ; Dendritic Cells - metabolism ; DNA - metabolism ; Enzyme Activation ; Female ; HeLa Cells - drug effects ; HeLa Cells - metabolism ; Humans ; I-kappa B Proteins - chemistry ; I-kappa B Proteins - genetics ; I-kappa B Proteins - physiology ; Interleukin-1 - pharmacology ; Lipopolysaccharides - pharmacology ; Lymphotoxin beta Receptor ; Lymphotoxin-alpha - agonists ; Lymphotoxin-alpha - pharmacology ; Lymphotoxin-beta ; Membrane Proteins - agonists ; Membrane Proteins - pharmacology ; NF-kappa B - metabolism ; NF-kappa B p52 Subunit ; NF-KappaB Inhibitor alpha ; Protein Binding - drug effects ; Protein Precursors - metabolism ; Protein Processing, Post-Translational ; Receptors, Tumor Necrosis Factor - agonists ; Receptors, Tumor Necrosis Factor - physiology ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - physiology ; Ribosomes - metabolism ; Sequence Deletion ; Tetradecanoylphorbol Acetate - pharmacology ; Trans-Activators - metabolism ; Transcription Factors ; Tumor Cells, Cultured - drug effects ; Tumor Cells, Cultured - metabolism ; Tumor Necrosis Factor Ligand Superfamily Member 14 ; Tumor Necrosis Factor-alpha - pharmacology ; Ubiquitin - metabolism</subject><ispartof>EMBO reports, 2003-01, Vol.4 (1), p.82</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12524526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mordmüller, Benjamin</creatorcontrib><creatorcontrib>Krappmann, Daniel</creatorcontrib><creatorcontrib>Esen, Meral</creatorcontrib><creatorcontrib>Wegener, Elmar</creatorcontrib><creatorcontrib>Scheidereit, Claus</creatorcontrib><title>Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism</title><title>EMBO reports</title><addtitle>EMBO Rep</addtitle><description>The 'classical' NF-kappaB activation pathway proceeds via IkappaB kinase (IKK)-beta/gamma-mediated phosphorylation, induced ubiquitination and the degradation of small IkappaBs. An alternative, NF-kappaB-inducing kinase and IKK-alpha-dependent pathway, which stimulates the processing of NF-kappaB2/p100, has recently been suggested. However, no physiological stimulus has been shown to trigger the activation of this pathway. Here we demonstrate that persistent stimulation with lymphotoxin beta (LT-beta) receptor agonists or lipopolysaccharide (LPS), but not with interleukin-1beta, tumour necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate, induces the generation of p52 DNA-binding complexes by activating the processing of the p100 precursor. Induction of p52 DNA-binding activity is delayed in comparison with p50/p65 complexes and depends on de novo protein synthesis. p100 is constitutively and inducibly polyubiquitinated, and both ubiquitination and p52 generation are coupled to continuing p100 translation. Thus, both LT-beta receptor agonists and LPS induce NF-kappaB/p100 processing to p52 at the level of the ribosome.</description><subject>Adaptor Proteins, Signal Transducing</subject><subject>Adenocarcinoma - pathology</subject><subject>B-Lymphocytes - drug effects</subject><subject>B-Lymphocytes - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Dendritic Cells - drug effects</subject><subject>Dendritic Cells - metabolism</subject><subject>DNA - metabolism</subject><subject>Enzyme Activation</subject><subject>Female</subject><subject>HeLa Cells - drug effects</subject><subject>HeLa Cells - metabolism</subject><subject>Humans</subject><subject>I-kappa B Proteins - chemistry</subject><subject>I-kappa B Proteins - genetics</subject><subject>I-kappa B Proteins - physiology</subject><subject>Interleukin-1 - pharmacology</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lymphotoxin beta Receptor</subject><subject>Lymphotoxin-alpha - agonists</subject><subject>Lymphotoxin-alpha - pharmacology</subject><subject>Lymphotoxin-beta</subject><subject>Membrane Proteins - agonists</subject><subject>Membrane Proteins - pharmacology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-kappa B p52 Subunit</subject><subject>NF-KappaB Inhibitor alpha</subject><subject>Protein Binding - drug effects</subject><subject>Protein Precursors - metabolism</subject><subject>Protein Processing, Post-Translational</subject><subject>Receptors, Tumor Necrosis Factor - agonists</subject><subject>Receptors, Tumor Necrosis Factor - physiology</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - physiology</subject><subject>Ribosomes - metabolism</subject><subject>Sequence Deletion</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription Factors</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Tumor Cells, Cultured - metabolism</subject><subject>Tumor Necrosis Factor Ligand Superfamily Member 14</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Ubiquitin - metabolism</subject><issn>1469-221X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKxDAYRrNQnHH0FSQvEMilSdOlDo4KRTezcDf8udSJtkloOmDf3qLO6oMD58B3gdasUg3hnL2v0HUpn5RS2dT6Cq0Yl7ySXK2RaechH9OUvkPEEB3uQ0459XMBa48wBudxiO5kPX7dkS_IGR5Ilhx_-OhHmEKK2MwYsE1kGiGW_pdBjwe_-DGU4QZddtAXf_u_G7TfPe63z6R9e3rZ3rdLrlKEG-eVkFwAE7YGpjspO83rhhkrQDAvALg11DSVYsJorTlVlCqQrjZsUTfo7i-bT2bw7pDHMMA4H85fxQ_m21Ac</recordid><startdate>200301</startdate><enddate>200301</enddate><creator>Mordmüller, Benjamin</creator><creator>Krappmann, Daniel</creator><creator>Esen, Meral</creator><creator>Wegener, Elmar</creator><creator>Scheidereit, Claus</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200301</creationdate><title>Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism</title><author>Mordmüller, Benjamin ; Krappmann, Daniel ; Esen, Meral ; Wegener, Elmar ; Scheidereit, Claus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p546-2bde63523a13c7a18f55f82791bc3a31e3aa2cb0b94613b888206006a5d7b1e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adaptor Proteins, Signal Transducing</topic><topic>Adenocarcinoma - pathology</topic><topic>B-Lymphocytes - drug effects</topic><topic>B-Lymphocytes - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Dendritic Cells - drug effects</topic><topic>Dendritic Cells - metabolism</topic><topic>DNA - metabolism</topic><topic>Enzyme Activation</topic><topic>Female</topic><topic>HeLa Cells - drug effects</topic><topic>HeLa Cells - metabolism</topic><topic>Humans</topic><topic>I-kappa B Proteins - chemistry</topic><topic>I-kappa B Proteins - genetics</topic><topic>I-kappa B Proteins - physiology</topic><topic>Interleukin-1 - pharmacology</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lymphotoxin beta Receptor</topic><topic>Lymphotoxin-alpha - agonists</topic><topic>Lymphotoxin-alpha - pharmacology</topic><topic>Lymphotoxin-beta</topic><topic>Membrane Proteins - agonists</topic><topic>Membrane Proteins - pharmacology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-kappa B p52 Subunit</topic><topic>NF-KappaB Inhibitor alpha</topic><topic>Protein Binding - drug effects</topic><topic>Protein Precursors - metabolism</topic><topic>Protein Processing, Post-Translational</topic><topic>Receptors, Tumor Necrosis Factor - agonists</topic><topic>Receptors, Tumor Necrosis Factor - physiology</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - physiology</topic><topic>Ribosomes - metabolism</topic><topic>Sequence Deletion</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription Factors</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Tumor Cells, Cultured - metabolism</topic><topic>Tumor Necrosis Factor Ligand Superfamily Member 14</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Ubiquitin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mordmüller, Benjamin</creatorcontrib><creatorcontrib>Krappmann, Daniel</creatorcontrib><creatorcontrib>Esen, Meral</creatorcontrib><creatorcontrib>Wegener, Elmar</creatorcontrib><creatorcontrib>Scheidereit, Claus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>EMBO reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mordmüller, Benjamin</au><au>Krappmann, Daniel</au><au>Esen, Meral</au><au>Wegener, Elmar</au><au>Scheidereit, Claus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism</atitle><jtitle>EMBO reports</jtitle><addtitle>EMBO Rep</addtitle><date>2003-01</date><risdate>2003</risdate><volume>4</volume><issue>1</issue><spage>82</spage><pages>82-</pages><issn>1469-221X</issn><abstract>The 'classical' NF-kappaB activation pathway proceeds via IkappaB kinase (IKK)-beta/gamma-mediated phosphorylation, induced ubiquitination and the degradation of small IkappaBs. An alternative, NF-kappaB-inducing kinase and IKK-alpha-dependent pathway, which stimulates the processing of NF-kappaB2/p100, has recently been suggested. However, no physiological stimulus has been shown to trigger the activation of this pathway. Here we demonstrate that persistent stimulation with lymphotoxin beta (LT-beta) receptor agonists or lipopolysaccharide (LPS), but not with interleukin-1beta, tumour necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate, induces the generation of p52 DNA-binding complexes by activating the processing of the p100 precursor. Induction of p52 DNA-binding activity is delayed in comparison with p50/p65 complexes and depends on de novo protein synthesis. p100 is constitutively and inducibly polyubiquitinated, and both ubiquitination and p52 generation are coupled to continuing p100 translation. Thus, both LT-beta receptor agonists and LPS induce NF-kappaB/p100 processing to p52 at the level of the ribosome.</abstract><cop>England</cop><pmid>12524526</pmid></addata></record>
fulltext fulltext
identifier ISSN: 1469-221X
ispartof EMBO reports, 2003-01, Vol.4 (1), p.82
issn 1469-221X
language eng
recordid cdi_pubmed_primary_12524526
source Electronic Journals Library; Wiley-Blackwell Journals; Open Access: PubMed Central; MEDLINE; Wiley Free Archive
subjects Adaptor Proteins, Signal Transducing
Adenocarcinoma - pathology
B-Lymphocytes - drug effects
B-Lymphocytes - metabolism
Breast Neoplasms - pathology
Dendritic Cells - drug effects
Dendritic Cells - metabolism
DNA - metabolism
Enzyme Activation
Female
HeLa Cells - drug effects
HeLa Cells - metabolism
Humans
I-kappa B Proteins - chemistry
I-kappa B Proteins - genetics
I-kappa B Proteins - physiology
Interleukin-1 - pharmacology
Lipopolysaccharides - pharmacology
Lymphotoxin beta Receptor
Lymphotoxin-alpha - agonists
Lymphotoxin-alpha - pharmacology
Lymphotoxin-beta
Membrane Proteins - agonists
Membrane Proteins - pharmacology
NF-kappa B - metabolism
NF-kappa B p52 Subunit
NF-KappaB Inhibitor alpha
Protein Binding - drug effects
Protein Precursors - metabolism
Protein Processing, Post-Translational
Receptors, Tumor Necrosis Factor - agonists
Receptors, Tumor Necrosis Factor - physiology
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - physiology
Ribosomes - metabolism
Sequence Deletion
Tetradecanoylphorbol Acetate - pharmacology
Trans-Activators - metabolism
Transcription Factors
Tumor Cells, Cultured - drug effects
Tumor Cells, Cultured - metabolism
Tumor Necrosis Factor Ligand Superfamily Member 14
Tumor Necrosis Factor-alpha - pharmacology
Ubiquitin - metabolism
title Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A18%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymphotoxin%20and%20lipopolysaccharide%20induce%20NF-kappaB-p52%20generation%20by%20a%20co-translational%20mechanism&rft.jtitle=EMBO%20reports&rft.au=Mordm%C3%BCller,%20Benjamin&rft.date=2003-01&rft.volume=4&rft.issue=1&rft.spage=82&rft.pages=82-&rft.issn=1469-221X&rft_id=info:doi/&rft_dat=%3Cpubmed%3E12524526%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12524526&rfr_iscdi=true